Oral low dose butyrate compositions
CA 2366650 A1 · Owner: Su, Michael · Inventors: Chaturvedi, Pravin; Su, Michael; Tung, Roger
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
This invention relates to orally available compositions which deliver an amount of butyrate or a butyrate analogue effective to ameliorate .beta.hemoglobinopathies, such as .beta.-thalassemia and sickle cell anemia cystic , fibrosis, cancer and other diseases which are known to be treatable with butyrate. The invention also relates to methods of treating these diseases with such low dose oral compositions.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed March 17, 2000. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended March 17, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by March 17, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.